Crystagen 20mg

Crystagen is a synthetic peptide bioregulator from the so-called Khavinson research line: the group of ultrashort peptides described at the St. Petersburg Institute of Bioregulation and Gerontology. Within scientific research, Crystagen is being studied as a model compound, with interest in immune- and thymus-related signaling pathways in controlled systems. The product is supplied as a freeze-dried powder (lyophilisate) of 20 mg per vial and is intended exclusively for laboratory and research purposes.

What is Crystagen?

Peptide bioregulators are short, synthetic peptides studied within the Khavinson research tradition as a tool to investigate peptide-mediated regulation in cell models. These compounds typically consist of only a few amino acids, making them an attractive model class for research into the relationship between minimal peptide structure and molecular recognition. Within this collection, crystagens are considered part of the subgroup associated with immune and thymic tissue in the literature.

Because public chemical registers for Crystagen do not list a clear, reliably verified amino acid sequence or registration number, we deliberately describe this compound without claiming a specific sequence or CAS number. In the specification table below, we include only data that can be reliably confirmed: class, strength, form, purity, and storage conditions. This aligns with the way the related ultra-short bioregulators in our range are presented.

Research areas

The following application areas are associated with this class of compounds in a laboratory context. These concern fields of research, not applications for humans or animals:

• Model compound in immunological research, including in vitro studies of T lymphocyte populations.
• Models of thymic epithelial cells and cellular differentiation in cell culture.
• Research into peptide-directed modulation of gene expression in controlled systems.
• Studies on the conformational stability and solubility of ultrashort synthetic peptides.
• Comparative peptide chemistry within the Khavinson family of short bioregulators.
• Structural characterization via HPLC and mass spectrometry as an analytical reference.

Crystagens compared to related compounds

Crystagen shares its background with a range of other short peptide bioregulators from the same research line. Whereas Crystagen is linked to immune and thymus tissue in the literature, Thymalin studied as a thymic peptide bioregulator and Vilon as a dipeptide bioregulator from the same tradition. For researchers who wish to compare the family of ultrashort bioregulators with defined sequences, are Cholelutes (Glu-Asp-Gly, EDG) and Test days (Lys-Glu-Asp-Gly, KEDG) useful reference points. Within research, these compounds are each treated as a separate model compound; mutual differences in amino acid composition make them suitable for comparative structural analyses.

Specifications

Rows such as CAS number, molecular formula, molecular weight, and PubChem CID have been deliberately omitted: for Crystagen, these cannot be confirmed from a reliable public source. We prefer not to include a value rather than an uncertain value.

Shape, handling and storage

Crystagen is offered as a sterile-looking, freeze-dried powder in a sealed 20 mg vial. The lyophilized powder is relatively stable in dry form and should be stored in a cool, dark, and dry place. For research use, the powder is reconstituted in a controlled environment with a suitable solvent; bacteriostatic water is the usual choice for dissolving lyophilized peptides in research. After reconstitution, the solution is stored refrigerated (2–8 °C) and protected from light. Avoid repeated temperature changes and use clean, calibrated equipment to maintain the integrity of the sample.

Want to know more? Read our guide: Bacteriostatic water: what is it used for and how do you mix it correctly?

Purity and lab results

Crystagen is offered with a controlled purity of ≥ 99%, determined via HPLC. Purity and identity are important parameters in analytical peptide research, as contaminants or degradation products can influence the interpretation of results. An overview of available analyses can be found on our website. lab results page.

Frequently Asked Questions

What exactly is Crystagen?
Crystagen is a short synthetic peptide bioregulator from the Khavinson research line, supplied as a 20 mg lyophilisate per vial. It is being studied as a model compound in scientific research.

Why don't you mention a sequence or CAS number?
For Crystagen, public sources do not provide a unique, reliably verified sequence or registration number. We choose to omit this data rather than display an uncertain value.

In what form is Crystagen supplied?
As a freeze-dried powder (lyophilisate) in a sealed 20 mg vial, intended for reconstitution in a laboratory context.

How do I store Crystagen?
Store the dry powder in a cool, dark, and dry place. After reconstitution, store refrigerated (2–8 °C) and protect from light.

Which related connections do you offer?
Among other things Vilon, Thymalin, Cholelutes and Test days from the same line of research.

Intended exclusively for laboratory and research purposes. Not for human or animal consumption, or for medical, diagnostic, therapeutic, or cosmetic use. The buyer is 18+ and confirms the research context. Not a medicine.